mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.5 |